Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

What You Should Know:

– Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel Network partnership with Belong.Life, a leading global provider of disease-specific AI-powered patient education and support solutions, to identify and connect qualified patients with clinical research.

– Through this partnership, Trialbee and Belong.Life will streamline the recruitment process and introduce clinical research to millions of patients in Belong’s dedicated communities for oncology, multiple-sclerosis, obesity and more. The goal of this collaboration is to increase trial enrollment by presenting relevant clinical trial opportunities to Belong.Life’s global network of patients seeking education, support, and resources related to their specific conditions.

Transforming Patient Recruitment with Trialbee’s Honey Platform™

Trialbee is redefining the patient recruitment landscape through innovative technology, dedicated people, and a passion for improving clinical trials. The company’s vendor-agnostic Honey Platform™ is a SaaS-based Patient Recruitment Platform (PRP) that centralizes and standardizes all recruitment activities across every source, channel, and partner, from initial interest to enrollment. This platform offers unparalleled transparency, actionable insights, and robust ROI reporting, resulting in higher-quality referrals that reduce site burden.

Read the Full article >

More Articles

Belong.Life Revolutionizing Patient Support

Belong.Life is transforming digital health with AI-driven platforms for patients communities, offering personalized guidance from health…

Eliran Malki Presents His Visionary Approach to AI in Healthcare

No one can dispute that AI in healthcare has consumed most all the air in…

Dave AI – a Revolutionary Tool for Cancer Patients

Promise and Peril of Instant Health Information Access for Consumers. Apps and AI Help Patients…
Skip to content